News

Christopher Henderson, Ph.D., joins as vice president, Neurology. Richard Ransohoff, M.D., joins as senior research fellow, Neuroimmunology. The addition of these top researchers bolsters Biogen Idec’s discovery engine.

The prospective, randomized, double-blind, placebo controlled trial was carried out in the US under a US Food and Drug Administration (FDA) Investigational New Drug (IND) protocol. The trial

Under the deal, Landsteiner will be responsible for securing regulatory and pricing approval, as well as the marketing and distribution of the drug. Iroko Pharmaceuticals president and CEO

AC-201 has shown the ability to inhibit the production and activity of caspase-1 and the cytokine Interleukin-1Beta (IL-1Beta) and to down-regulate IL-1Beta receptors. Inhibition of IL-1Beta signaling has

In 2007 CHPA members voluntarily withdrew infant cough and cold products and added further voluntary label changes in 2008 for use only in children ages 4 and older.

Plandaí’s unique and proprietary process known as "hydrodynamic sheering" which unzips the molecules of the "live" green tea plant, releases all of the phytonutrients, and then rearranges the

The fully human antibody, recovered from patients undergoing cancer vaccine treatment at Memorial Sloan-Kettering Cancer Center, has entered GMP manufacturing to produce clinical trial supplies for a planned

Dekel’s product candidates target indications including chronic pain and inflammation. In addition to its cannabinoid-related R&D drug programs, Dekel holds the IP rights to a disposable, dose-controlled inhalation

Around 80 patients will be enrolled in the trial across three sites including The University of Texas MD Anderson Cancer Center, the Sarah Cannon Research Institute and the